WASHINGTON— Federal health regulators have approved an attention deficit disorder drug for a new use: A first-of-its kind treatment for binge-eating disorder. About 2 percent of U.S. adults, or about 5 million people, have binge eating disorder, according to the Department of Health and Human Services. The Food and Drug Administration originally approved...» Read More
Marvina is a premium cannabis provider that offers a monthly delivery service of marijuana to consumers in San Francisco.
Regeneron Pharmaceuticals CEO Dr. Leonard Schleifer told CNBC on Tuesday that benefits companies should not try to practice medicine.
Months after he landed in Florida's Manatee County Jail, Jovon Frazier's pleas for treatment of the intense pain that radiated from his left shoulder to his elbow were met mostly with Tylenol. Frazier, then 18, wrote the second time he asked for care, in August 2009. That company, Corizon Health Inc., is under growing pressure around the country after losing five...
The Justice Department kept a secret database of incoming and outgoing U.S. international calls for more than a decade.
"Any event in life changes one. That was an event that probably changed me in many ways. I think I am a better person," biotech company founder Sam Waksal.
Rather than pay so much out-of-pocket, many skip checkups and scrimp on care, USA Today reports.
This flu season is ramping up earlier than last year's, NBC News reports.
Hallucinogenic mushrooms have been discovered on the grounds of Buckingham Palace in London, NBC News reports.
Dec 10- Philadelphia's transportation authority has filed a class action lawsuit accusing Gilead Sciences Inc of charging "exorbitant" prices for its blockbuster hepatitis C drug Sovaldi. The lawsuit, filed Tuesday in federal court in Philadelphia by the Southeastern Pennsylvania Transportation Authority, seeks an unspecified amount of money damages.
Doctors who used Genentech's expensive eye drug Lucentis were also among the highest-paid consultants for the company, reports the New York Times.
Drug giant Merck said it will buy Cubist and its slate of medicines administered in hospitals, many for bacterial infections, for about $9.5 billion.
Generic drug costs have risen so much that some drugs have surpassed their equivalents in other developed countries, the New York Times reports.
There is no escaping the fact that we’re all getting older, and investors are having to find new ways to make money from changes in the way we age.
Bob Marley heirs say they are creating a pot-focused brand dubbed Marley Natural, reports NBC News.
DEA agents questioned medical-staff members from several NFL teams in a continuing investigation into distribution of painkillers, The NYT reports.
Law enforcement agencies around the globe undertook action against so-called "dark markets" running anonymously on the "Tor" network, on Thursday.
Two Jefferies executives marched with other company bankers to take drug tests in solidarity with Sage Kelly, reports the New York Times.
Along the Myanmar-China border, where heroin addiction is common, fresh needles are now so coveted that shopkeepers dispense them as change.
A nasty Wall Street divorce has touched two biotech CEOs and appears to have moved their company stocks down over drug use allegations.
Health care has been on a tear in 2014, and there is still room for upside. Wall Street analysts are focusing on the following four trends.